America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Index funds offer a simple, cost-efficient path to retirement growth, combining broad market exposure with minimal management. This overview explains the appeal.
22,512 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
The spotlight in AI investing is shifting from screens to factories. The BOTZ ETF is positioning itself to ride a wav...
A fast acquittal may clear charges, but the financial fallout can linger for years. This guide explains how the phras...
Tech leadership returned to the forefront as semiconductors boosted Nasdaq in July trading. This article breaks down ...
President Trump arrives in Beijing for high-stakes talks with Xi Jinping, pressing to open up China for American inve...
The annual Sun Valley meeting is pivoting from legacy media power to AI and software influence, signaling a new era f...
Through mid-May 2026, VXUS has risen about 10% year-to-date, narrowly surpassing the S&P 500’s roughly 8% gain. The m...
Bitcoin remains mired in a bear market as macro forces and investor psychology shape price action. An analyst predict...
A Florida biologist and state agency reach a $485,000 settlement over her firing tied to social media comments about ...
More than 200 economists, including 16 Nobel laureates, sign a call admitting they lack clarity on AI's economic effe...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...
Bitcoin often sparks fierce arguments: is it dead or just resting? This article breaks down three substantial concern...